San Diego Union-Tribune

PARENTS, STEP UP

- The Washington Post is a professor at George Washington University’s Milken Institute School of Public Health.

Finally, relief for parents of young children is here: Children under 5 years old will almost certainly be able to get their coronaviru­s vaccines starting next week. This will make a huge difference to many families — mine included — who have been desperate to protect their kids against the coronaviru­s.

External advisers to the Food and Drug Administra­tion voted on Wednesday to recommend authorizat­ion of both the PfizerBioN­Tech and Moderna vaccines for children 6 months to 5 years old. An advisory committee to the Centers for Disease Control and Prevention will now meet today and Saturday. Given the strength of the data and the pressing need to make vaccines available to all, I expect the CDC will follow with its own green light.

The Biden administra­tion has already made 10 million doses available for pre-order by states, pharmacies and health centers. That means parents may begin taking their young kids to be vaccinated by early next week.

I will be among those eager parents. Throughout the pandemic, my concern about COVID-19 has not been for me and my husband, but for our children. Our daughter was born in April 2020 in the height of uncertaint­y and fear. Our son, now almost 5 years old, had to stop preschool when the coronaviru­s first hit. Even after school resumed, we kept him out of many childhood activities and only recently resumed extracurri­culars and indoor playdates.

It’s true that young children like mine are unlikely to suffer severe outcomes from COVID-19. But it’s also true that some kids have. More than 400 children under 5 years old have died from COVID-19. Thousands have been hospitaliz­ed. The risk of long COVID for children is probably far less than for adults, but it remains a major concern for many families.

Parents have to assess all kinds of risks for our kids. As I’ve maintained throughout the pandemic, the risk of any activity has to be balanced against its value. Just because something is risky doesn’t mean we have to avoid it — which is how I’ve thought about in-person, mask-optional school and the resumption of social activities for our unvaccinat­ed kids. But I’ll have more peace of mind if I can reduce their risk with an interventi­on that’s safe and effective.

And that’s what these vaccines are. The FDA’s analyses of company data show both the Pfizer and Moderna vaccines induce a robust antibody response that’s as strong as the response in adolescent­s and young adults. In all other age groups, this level of antibody increase correlates with protection against severe disease, and it stands to reason that it does in this younger age group, too.

Plus, both vaccines protect against symptomati­c disease. Pfizer’s reduces COVID-19 by 76 percent for 6-month- to 2-yearsolds and 82 percent for 2- to 5-year-olds. Moderna’s is 51 percent and 37 percent effective for 6-month- to 2-year-olds and for 2- to 5-year-olds, respective­ly.

These numbers are comparable to the protection for older age groups against omicron. Pfizer’s higher efficacy is likely explained by the fact that its vaccine for young kids is a three-dose series. Moderna’s, on the other hand, is a two-dose vaccine.

The other key difference

It’s been a year and a half since adults first got their shots. Finally, our youngest will no longer be left behind.

between the two vaccines is the dosage. Pfizer’s vaccine is 3 micrograms, which is one-tenth of the adult dose. Moderna’s is 25 micrograms, or one-quarter of the adult primary series. Both dosages, either as three shots or two, were found to be safe, with no new adverse reactions and no cases of myocarditi­s in the thousands of children in clinical trials.

I am convinced by these data and reassured by the thoughtful, rigorous process undertaken by federal regulators. Many families will be, too, though they are in the minority. According to a Kaiser Family Foundation survey, less than 1 in 5 parents intend to vaccinate their kids under 5 years old right away. Another 38 percent say they’ll wait and see. These numbers track with the uptake of pediatric coronaviru­s vaccines overall; only 29 percent of kids 5 to 11 years old have been vaccinated, despite overwhelmi­ng evidence for safety and effectiven­ess.

Even if it’s unlikely to change the trajectory of the pandemic, having this youngest age group eligible for vaccinatio­n is an important milestone. It’s been a year and a half since adults first started their inoculatio­ns. Finally, our youngest children will no longer be left behind.

Wen

Newspapers in English

Newspapers from United States